Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 101–200 of 1,001
Fatty Acids and NLRP3 Inflammasome–Mediated Inflammation in Metabolic Tissues
Ralston, J. C., Lyons, C. L., Kennedy, E. B., Kirwan, A. M., & Roche, H. M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064836 · Cited by 225
Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor
Suzuki, M., Takaishi, S., Nagasaki, M., Onozawa, Y., Iino, I., Maeda, H., Komai, T., & Oda, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.420042 · Cited by 218
Role of GPR40 in fatty acid action on the β cell line INS-1E
Shapiro, H., Shachar, S., Sekler, I., Hershfinkel, M., & Walker, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.042 · Cited by 220
Glucagon-Like Peptide 1 Secretion by the L-Cell
Lim, G. E., & Brubaker, P. L. (2006) · Diabetes · doi:10.2337/db06-s020 · Cited by 223
Nutrient regulation of insulin secretion and action
Newsholme, P., Cruzat, V., Arfuso, F., & Keane, K. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0616 · Cited by 218
“Furthermore, other artificial sweeteners could modulate GSIS in this cell line, and evidence was provided to show that changes in insulin secretion were modulated through alterations in b -cell Ca 2 C and/or cAMP handling (Nakagawa et al .”
BackgroundInfluentialCheng, J., Hu, H., Ju, Y., Liu, J., Wang, M., Liu, B., & Zhang, Y. (2024) · General Psychiatry · doi:10.1136/gpsych-2023-101374 · Cited by 196
Nutritional Signaling via Free Fatty Acid Receptors
Miyamoto, J., Hasegawa, S., Kasubuchi, M., Ichimura, A., Nakajima, A., & Kimura, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040450 · Cited by 214
“LCFAs promote glucose-stimulated insulin secretion (GSIS) in pancreatic β cells, and the specific and acute effects of FFAs were mitigated by the loss of GPR40 function [19].”
BackgroundHauge, M., Vestmar, M. A., Husted, A. S., Ekberg, J. P., Wright, M. J., Di Salvo, J., Weinglass, A. B., Engelstoft, M. S., Madsen, A. N., Lückmann, M., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.10.002 · Cited by 207
Kumar, D. P., Rajagopal, S., Mahavadi, S., Mirshahi, F., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.104 · Cited by 206
Magnificent seven: roles of G protein-coupled receptors in extracellular sensing in fungi
Xue, C., Hsueh, Y.-P., & Heitman, J. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00131.x · Cited by 207
“GPR40 mediates the majority of the effects of FFAs on insulin secretion.”
BackgroundInfluentialHow to Measure Adipose Tissue Insulin Sensitivity
Søndergaard, E., Espinosa De Ycaza, A. E., Morgan-Bathke, M., & Jensen, M. D. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00047 · Cited by 198
Molven, A., Matre, G. E., Duran, M., Wanders, R. J., Rishaug, U., Njølstad, P. R., Jellum, E., & Søvik, O. (2004) · Diabetes · doi:10.2337/diabetes.53.1.221 · Cited by 203
The Identification of Ligands at Orphan G-Protein Coupled Receptors
Wise, A., Jupe, S. C., & Rees, S. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121419 · Cited by 201
The L-cell in nutritional sensing and the regulation of appetite
Spreckley, E. (2015) · Frontiers in Nutrition · doi:10.3389/fnut.2015.00023 · Cited by 198
“FFAR1 is expressed in the pancreatic β-cell, where evidence suggests it can influence glucose-stimulated insulin release (197).”
BackgroundChronic Intake of High-Fat and High-Sucrose Diets Differentially Affects Glucose Intolerance in Mice
Sumiyoshi, M., Sakanaka, M., & Kimura, Y. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.3.582 · Cited by 198
An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans
Amisten, S., Salehi, A., Rorsman, P., Jones, P. M., & Persaud, S. J. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.004 · Cited by 196
The G Protein-Coupled Taste Receptor T1R1/T1R3 Regulates mTORC1 and Autophagy
Wauson, E. M., Zaganjor, E., Lee, A.-Y., Guerra, M. L., Ghosh, A. B., Bookout, A. L., Chambers, C. P., Jivan, A., McGlynn, K., Hutchison, M. R., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.001 · Cited by 197
“The fact that other GPCRs such as GPR40 mediate some actions of free fatty acids has demonstrated that nutrients have the potential to regulate cell signaling and metabolism at extracellular as well as intracellular levels in mammals (Itoh et al., 2003).”
BackgroundHudson, B. D., Shimpukade, B., Mackenzie, A. E., Butcher, A. J., Pediani, J. D., Christiansen, E., Heathcote, H., Tobin, A. B., Ulven, T., & Milligan, G. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087783 · Cited by 198
“To date, FFA1 has received the greatest attention based on clear validation as a target for the treatment of type 2 diabetes because of its ability to enhance glucosestimulated insulin secretion (Itoh et al., 2003); at least one FFA1 agonist has progressed through phase II clinical trials for this prospective end poin…”
BackgroundSyed, I., Lee, J., Moraes-Vieira, P. M., Donaldson, C. J., Sontheimer, A., Aryal, P., Wellenstein, K., Kolar, M. J., Nelson, A. T., Siegel, D., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.001 · Cited by 197
“The long-chain fatty acid receptor GPR40 is the most abundant GPCR expressed in islet b cells and is also expressed on intestinal L-cells, where it contributes to GLP-1 release along with GPR120 (Itoh et al., 2003; Edfalk et al., 2008).”
InfluentialStitzel, M. L., Sethupathy, P., Pearson, D. S., Chines, P. S., Song, L., Erdos, M. R., Welch, R., Parker, S. C. J., Boyle, A. P., Scott, L. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.012 · Cited by 193
“Regulates insulin secretion (Itoh et al., 2003) SYT4 Involved in Ca-dependent trafficking and exocytosis of secretory vesicles (Tsuboi and Rutter, 2003)”
Effects of palmitate on ER and cytosolic Ca2+homeostasis in β-cells
Gwiazda, K. S., Yang, T.-L. B., Lin, Y., & Johnson, J. D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90525.2008 · Cited by 195
Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo
Fujita, Y., Wideman, R. D., Speck, M., Asadi, A., King, D. S., Webber, T. D., Haneda, M., & Kieffer, T. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90636.2008 · Cited by 196
“insulin secretion from pancreatic -cells (26), was subse-”
BackgroundFree fatty acid receptors act as nutrient sensors to regulate energy homeostasis
Ichimura, A., Hirasawa, A., Hara, T., & Tsujimoto, G. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.003 · Cited by 191
Roduit, R., Nolan, C., Alarcon, C., Moore, P., Barbeau, A., Delghingaro-Augusto, V., Przybykowski, E., Morin, J., Massé, F., Massie, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1007 · Cited by 192
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
Tenenbaum, A., Klempfner, R., & Fisman, E. Z. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-2085133501150912 · Cited by 186
Nagasumi, K., Esaki, R., Iwachidow, K., Yasuhara, Y., Ogi, K., Tanaka, H., Nakata, M., Yano, T., Shimakawa, K., Taketomi, S., et al. (2009) · Diabetes · doi:10.2337/db08-1233 · Cited by 188
“2 kbp of the hGPR40 gene, including the 3 noncoding region (8), and the complete 2.”
BackgroundSelf-citationJoyal, J.-S., Gantner, M. L., & Smith, L. E. H. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.002 · Cited by 185
“First discovered in the pancreas, Ffar1 regulates insulin secretion (Itoh et al., 2003).”
BackgroundG-protein-coupled receptors and islet function—Implications for treatment of type 2 diabetes
Winzell, M. S., & Ahrén, B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.002 · Cited by 183
“GPR40 is coupled to Gαq with a subsequent increase in cytosolic Ca2+ concentration (Itoh et al., 2003), although also a mechanism through activation of PLC has been proposed (Feng et al., 2006; Fujiwara et al., 2005; Shapiro et al., 2005).”
BackgroundInfluentialAcetylene Group, Friend or Foe in Medicinal Chemistry
Talele, T. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01617 · Cited by 176
Mattes, R. D. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141108 · Cited by 181
Katsuma, S., Hatae, N., Yano, T., Ruike, Y., Kimura, M., Hirasawa, A., & Tsujimoto, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412385200 · Cited by 178
The eukaryotic plasma membrane as a nutrient-sensing device
HOLSBEEKS, I., LAGATIE, O., VANNULAND, A., VANDEVELDE, S., & THEVELEIN, J. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.08.010 · Cited by 180
Oleate Promotes the Proliferation of Breast Cancer Cells via the G Protein-coupled Receptor GPR40
Hardy, S., St-Onge, G. G., Joly, É., Langelier, Y., & Prentki, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410922200 · Cited by 175
Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β ‐cells
Gehrmann, W., Elsner, M., & Lenzen, S. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01265.x · Cited by 173
“And in fact, NEFA-mediated potentiating effects are reduced in parallel with a reduction of GPR40 expression [24,29].”
BackgroundIdentification of a G Protein-coupled Receptor Specifically Responsive to β-Alanine
Shinohara, T., Harada, M., Ogi, K., Maruyama, M., Fujii, R., Tanaka, H., Fukusumi, S., Komatsu, H., Hosoya, M., Noguchi, Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314240200 · Cited by 175
Self-citationFree Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors
Offermanns, S. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135945 · Cited by 171
The Fatty Acid Receptor GPR40 Plays a Role in Insulin Secretion In Vivo After High-Fat Feeding
Kebede, M., Alquier, T., Latour, M. G., Semache, M., Tremblay, C., & Poitout, V. (2008) · Diabetes · doi:10.2337/db08-0553 · Cited by 169
“We found GPR120 mRNA to be expressed in isolated mouse islets, although its expression did not increase in compensation for the absence of GPR40 in GPR40 KO islets (Table 1).”
BackgroundInfluentialFree fatty acid receptors as therapeutic targets for the treatment of diabetes
Ichimura, A., Hasegawa, S., Kasubuchi, M., & Kimura, I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00236 · Cited by 170
“In this report, it was shown that FFAR1 is expressed in pancreatic β cells, and that the specific and acute effects of FFAs on pancreatic β cells were significantly decreased following the loss of FFAR1 function (Itoh et al., 2003).”
BackgroundInfluentialGPR expression in the rat taste bud relating to fatty acid sensing
MATSUMURA, S., MIZUSHIGE, T., YONEDA, T., IWANAGA, T., TSUZUKI, S., INOUE, K., & FUSHIKI, T. (2007) · Biomedical Research · doi:10.2220/biomedres.28.49 · Cited by 168
Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)
Schreiber, R., Xie, H., & Schweiger, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.10.008 · Cited by 169
Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
Larrieu, T., & Layé, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01047 · Cited by 162
Role of free fatty acid receptors in the regulation of energy metabolism
Hara, T., Kashihara, D., Ichimura, A., Kimura, I., Tsujimoto, G., & Hirasawa, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.06.002 · Cited by 168
Dietary influences on intestinal immunity
Veldhoen, M., & Brucklacher-Waldert, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3299 · Cited by 162
Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs
Im, D.-S. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.02.003 · Cited by 162
“FFAR1, which recognizes medium-long chain fatty acids like palmitic acid and linoleic acid [62,63], enhances glucose-induced insulin secretion in pancreatic b cells [63].”
BackgroundTan, C. P., Feng, Y., Zhou, Y.-P., Eiermann, G. J., Petrov, A., Zhou, C., Lin, S., Salituro, G., Meinke, P., Mosley, R., et al. (2008) · Diabetes · doi:10.2337/db08-0130 · Cited by 163
The organization and consequences of eicosanoid signaling
Soberman, R. J., & Christmas, P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18338 · Cited by 162
“In addition, the recent discovery of a G protein–coupled receptor for arachidonic acid indicates that even the lack of enzymatic oxygen can import biological information mediated by arachidonic acid (97).”
BackgroundLee, J.-W., Huang, B. X., Kwon, H., Rashid, M. A., Kharebava, G., Desai, A., Patnaik, S., Marugan, J., & Kim, H.-Y. (2016) · Nature Communications · doi:10.1038/ncomms13123 · Cited by 161
Ferdaoussi, M., Bergeron, V., Zarrouki, B., Kolic, J., Cantley, J., Fielitz, J., Olson, E. N., Prentki, M., Biden, T., MacDonald, P. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2650-x · Cited by 160
“Since its deorphanisation as a GPCR activated by medium- to long-chain fatty acids [4–6], GPR40 received considerable attention as potential target for type 2 diabetes therapy.”
BackgroundResultInfluentialIdentification of a lysophosphatidylserine receptor on mast cells
Sugo, T., Tachimoto, H., Chikatsu, T., Murakami, Y., Kikukawa, Y., Sato, S., Kikuchi, K., Nagi, T., Harada, M., Ogi, K., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.069 · Cited by 159
Self-citationFatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors
Falomir-Lockhart, L. J., Cavazzutti, G. F., Giménez, E., & Toscani, A. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00162 · Cited by 161
Hidalgo, M. A., Carretta, M. D., & Burgos, R. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.668330 · Cited by 173
“Since FFA1 receptor agonists in β-pancreatic cells increase glucose-dependent insulin release (Briscoe et al., 2003; Itoh et al., 2003), basic FFA1 receptorrelated research has mainly focused on investigating its potential use in diabetes mellitus therapy (Burant, 2013; Mohammad, 2016).”
BackgroundFree Fatty Acid Receptors FFAR1 and GPR120 as Novel Therapeutic Targets for Metabolic Disorders
Hara, T., Hirasawa, A., Ichimura, A., Kimura, I., & Tsujimoto, G. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22639 · Cited by 166
Molecular mechanisms underlying health benefits of tea compounds
Shang, A., Li, J., Zhou, D.-D., Gan, R., & Li, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.006 · Cited by 170
Free Fatty Acid Receptors and Their Role in Regulation of Energy Metabolism
Hara, T., Kimura, I., Inoue, D., Ichimura, A., & Hirasawa, A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_13 · Cited by 173
Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis
Dezaki, K., Sone, H., & Yada, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.008 · Cited by 178
“However, ghrelin attenuation of insulin release appears not to be mediated by PLC signaling pathways, since PLC activation operated by muscarinic ACh receptor for parasympathetic nerve input (Ahrén, 2000; Gilon & Henquin, 2001) and GPR40 receptors specific for free fatty acids (Briscoe et al., 2003; Itoh et al., 2003)…”
The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
Mancini, A. D., & Poitout, V. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.003 · Cited by 179
Vilas‐Boas, E. A., de Almeida, D. C., Roma, L. P., Ortis, F., & Carpinelli, Â. R. (2021) · Cells · doi:10.3390/cells10123328 · Cited by 182
“GPR40 is expressed in rat and mice pancreatic islets [32] and in insulin-secreting cell lines [25,26].”
BackgroundLife and death decisions of the pancreatic β-cell: the role of fatty acids
Newsholme, P., Keane, D., Welters, H. J., & Morgan, N. G. (2007) · Clinical Science · doi:10.1042/cs20060115 · Cited by 155
Free Fatty Acid Receptors and Drug Discovery
Hirasawa, A., Hara, T., Katsuma, S., Adachi, T., & Tsujimoto, G. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1847 · Cited by 154
The islet β-cell: fuel responsive and vulnerable
Nolan, C. J., & Prentki, M. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.006 · Cited by 188
Fatty Acid Transport and Signaling: Mechanisms and Physiological Implications
Samovski, D., Jácome-Sosa, M., & Abumrad, N. A. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-032122-030352 · Cited by 177
Molecular Pharmacology of Promiscuous Seven Transmembrane Receptors Sensing Organic Nutrients
Wellendorph, P., Johansen, L. D., & Bräuner‐Osborne, H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055244 · Cited by 171
“This hypothesis has been substantiated by several studies using FFA1 knockout mice and selective FFA1 small-molecule agonists, showing that FFA1 regulates the FFA-mediated release of gastric inhibitory peptide and GLP-1 from the gut and the FFA-mediated enhancement of insulin release from -cells of the pancreas (Itoh…”
BackgroundMethodInfluentialMechanism of fat taste perception: Association with diet and obesity
Liu, D., Archer, N., Duesing, K., Hannan, G. N., & Keast, R. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.03.002 · Cited by 179
“That is, LCFAs may bind to CD36, followed by the communication with GPCR (most likely GPR120) and thus trigger intracellular signal transduction.”
BackgroundInfluentialSalehi, A., Flodgren, E., Nilsson, N. E., Jimenez-Feltstrom, J., Miyazaki, J., Owman, C., & Olde, B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0017-z · Cited by 150
“(Itoh et al. 2003) showed no differences between saturated and unsaturated”
BackgroundResultInfluentialThe G-protein-coupled receptor 40 family (GPR40–GPR43) and its role in nutrient sensing
Covington, D. K., Briscoe, C. A., Brown, A. J., & Jayawickreme, C. K. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340770 · Cited by 151
Han, L., Xia, J., Liang, Q., Wang, Y., Wang, Y., Hu, P., Li, P., & Luo, G. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.01.034 · Cited by 155
Kolar, M. J., Konduri, S., Chang, T., Wang, H., McNerlin, C., Ohlsson, L., Härröd, M., Siegel, D. R., & Saghatelian, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006956 · Cited by 155
A Family of Fatty Acid Binding Receptors
Brown, A. J., Jupe, S., & Briscoe, C. P. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.54 · Cited by 149
“GPR40 activation results in transient elevation of intracellular calcium and downstream MAP kinase activation characteristic of G (cid:2) q (Briscoe et al ., 2003; Itoh et al., 2003; Kotarsky et al ., 2003a).”
Tikhonova, I. G., Sum, C. S., Neumann, S., Engel, S., Raaka, B. M., Costanzi, S., & Gershengorn, M. C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7012425 · Cited by 149
Yi, L., He, J., Liang, Y., Yuan, D., & Chau, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.043 · Cited by 155
Flowers, J. B., Rabaglia, M. E., Schueler, K. L., Flowers, M. T., Lan, H., Keller, M. P., Ntambi, J. M., & Attie, A. D. (2007) · Diabetes · doi:10.2337/db06-1142 · Cited by 148
Schnell, S., Schaefer, M., & Schöfl, C. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.09.013 · Cited by 169
Carboxypeptidase E mediates palmitate-induced β-cell ER stress and apoptosis
Jeffrey, K. D., Alejandro, E. U., Luciani, D. S., Kalynyak, T. B., Hu, X., Li, H., Lin, Y., Townsend, R. R., Polonsky, K. S., & Johnson, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711232105 · Cited by 146
“These results argue against a prominent role in -cell death for the G protein-coupled FFA receptor GPR40, which nevertheless appears to be involved in -cell Ca2 signaling and insulin secretion (48, 49).”
ResultTsujihata, Y., Ito, R., Suzuki, M., Harada, A., Negoro, N., Yasuma, T., Momose, Y., & Takeuchi, K. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183772 · Cited by 156
“Although it has been reported that GPR40/FFA1 is expressed not only in pancreatic cells (insulin-positive cells) but also in cells (glucagon-positive cells) in mice (Flodgren et al., 2007), expression in insulin-positive cells is dominant in rats and humans (Itoh et al., 2003; Tomita et al., 2006).”
BackgroundMethodInfluentialTRPV1 is a novel target for omega‐3 polyunsaturated fatty acids
Matta, J. A., Miyares, R. L., & Ahern, G. P. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.121988 · Cited by 159
“BSA inhibited fatty-acid-evoked TRPV1 currents, presumably by binding free fatty acids as previously described (Itoh et al. 2003).”
BackgroundAtrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
Birkenfeld, A. L., Budziarek, P., Boschmann, M., Moro, C., Adams, F., Franke, G., Berlan, M., Marques, M. A., Sweep, F. C. G. J., Luft, F. C., et al. (2008) · Diabetes · doi:10.2337/db08-0649 · Cited by 146
“Acutely, FFAs together with an increase in glucose concentrations induce an exaggerated insulin response (31).”
BackgroundThe endocrinology of taste receptors
Calvo, S. S.-C., & Egan, J. M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.7 · Cited by 162
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
Gagnon, L., Leduc, M., Thibodeau, J.-F., Zhang, M.-Z., Grouix, B., Sarra-Bournet, F., Gagnon, W., Hince, K., Tremblay, M., Geerts, L., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.01.009 · Cited by 138
Novel selective ligands for free fatty acid receptors GPR120 and GPR40
Hara, T., Hirasawa, A., Sun, Q. L., Sadakane, K., Itsubo, C., Iga, T., Adachi, T., Koshimizu, T., Hashimoto, T., Asakawa, Y., et al. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0425-9 · Cited by 158
Dragano, N. R. V., Solon, C., Ramalho, A. F., de Moura, R. F., Razolli, D. S., Christiansen, E., Azevedo, C., Ulven, T., & Velloso, L. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0869-7 · Cited by 140
“A number of studies have also shown the beneficial metabolic effects of GPR40 activation [20, 25, 26].”
BackgroundFryk, E., Olausson, J., Mossberg, K., Strindberg, L., Schmelz, M., Brogren, H., Gan, L., Piazza, S., Provenzani, A., Becattini, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103264 · Cited by 163
Luo, J., Swaminath, G., Brown, S. P., Zhang, J., Guo, Q., Chen, M., Nguyen, K., Tran, T., Miao, L., Dransfield, P. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046300 · Cited by 138
“plethora of long-chain fatty acids [1,2].”
BackgroundHigher level of faecal SCFA in women correlates with metabolic syndrome risk factors
Teixeira, T. F. S., Grześkowiak, Ł., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., & Peluzio, M. C. G. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002723 · Cited by 137
Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
Watson, S., Brown, A., & Holliday, N. D. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.077388 · Cited by 164
“The absence of a PTX effect on GPR120S DMR measurements (other than a small reduction in GW9508 potency) contrasts with results of studies using FFA1, in which the potential for Gi/o as well as predominant Gq/11 coupling has been suggested (Itoh et al., 2003; Kotarsky et al., 2003), most convincingly by DMR (Schröder…”
BackgroundResultInfluentialAMG 837: A potent, orally bioavailable GPR40 agonist
Houze, J. B., Zhu, L., Sun, Y., Akerman, M., Qiu, W., Zhang, A. J., Sharma, R. K., Schmitt, M., Wang, Y., Liu, J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.118 · Cited by 143
Sampey, B. P., Freemerman, A. J., Zhang, J., Kuan, P.-F., Galanko, J. A., O'Connell, T. M., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Newgard, C. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038812 · Cited by 136
“Signaling through pattern recognition receptors including TLRs and GPCRs have been implicated in saturated fatty acid-mediated inflammation, especially lauric acid TLR-mediated activation of NFKB through the MyD88 pathway [23,65–77]; it is unclear if lauroyl carnitine can also activate these receptors.”
BackgroundLysophosphatidylcholine as an effector of fatty acid-induced insulin resistance
Han, M. S., Lim, Y.-M., Quan, W., Kim, J. R., Chung, K. W., Kang, M., Kim, S., Park, S. Y., Han, J.-S., Park, S.-Y., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014787 · Cited by 135
Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system
Nakamoto, K., Nishinaka, T., Matsumoto, K., Kasuya, F., Mankura, M., Kōyama, Y., & Tokuyama, S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.012 · Cited by 148
“There are, however, few reports regarding the role and functions of GPR40 in the brain even though this receptor is widely distributed in the CNS (Itoh et al., 2003).”
Kaku, K., Enya, K., Nakaya, R., Ohira, T., & Matsuno, R. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12467 · Cited by 148
A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling
Vagena, E., Ryu, J. K., Baeza-Raja, B., Walsh, N. M., Syme, C., Day, J. P., Houslay, M. D., & Baillie, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0470-1 · Cited by 132
Sharma, D., Tekade, R. K., & Kalia, K. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153235 · Cited by 132
Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it?
Nolan, C. J., & Larter, C. Z. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05823.x · Cited by 134
Wu, Q., Wang, H., Zhao, X., Shi, Y., Jin, M., Wan, B., Xu, H., Cheng, Y., Ge, H., & Zhang, Y. (2013) · Oncogene · doi:10.1038/onc.2013.264 · Cited by 134
Iwasaki, K., Harada, N., Sasaki, K., Yamane, S., Iida, K., Suzuki, K., Hamasaki, A., Nasteska, D., Shibue, K., Joo, E., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1653 · Cited by 132
“Previous in vitro studies using GPR40- and GPR120-expressing cells show that both receptor signalings are induced by very similar medium-chain and long-chain fatty acids (23, 38).”
Integrating the inputs that shape pancreatic islet hormone release
Noguchi, G. M., & Huising, M. O. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0148-2 · Cited by 131
Role of Medium-Chain Fatty Acids in Healthy Metabolism: A Clinical Perspective
Huang, L., Gao, L., & Chen, C. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.03.002 · Cited by 145
Modulation of Osteoclastogenesis by Fatty Acids
Cornish, J., MacGibbon, A., Lin, J.-M., Watson, M., Callon, K. E., Tong, P. C., Dunford, J. E., van der Does, Y., Williams, G. A., Grey, A. B., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0111 · Cited by 128
Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin
Ito, M., Yamamoto, S., Nimura, K., Hiraoka, K., Tamai, K., & Kaneda, Y. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.753 · Cited by 127
“siRNA was successfully introduced into pancreatic islet cell lines using the HVJ envelope vector [30].”
MethodLiu, L., Li, Y., Guan, C., Li, K., Wang, C., Feng, R., & Sun, C. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.08.035 · Cited by 127
Accumulating evidence supports a taste component for free fatty acids in humans
Mattes, R. D. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.05.002 · Cited by 147
“FFA application results in a rise of free intracellular calcium [71], but esterified fats are not effective [72].”
Background
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.